These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30218425)

  • 1. Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk.
    Mitchell D; Guertin JR; LeLorier J
    Mol Diagn Ther; 2018 Dec; 22(6):641-652. PubMed ID: 30218425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.
    Mitchell D; Guertin JR; Dubois A; Dubé MP; Tardif JC; Iliza AC; Fanton-Aita F; Matteau A; LeLorier J
    Mol Diagn Ther; 2018 Apr; 22(2):241-254. PubMed ID: 29651791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin.
    Mitchell D; Guertin JR; Iliza AC; Fanton-Aita F; LeLorier J
    Mol Diagn Ther; 2017 Feb; 21(1):95-105. PubMed ID: 27798813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a detection algorithm for statin-induced myopathy using electronic medical records.
    Sai K; Hanatani T; Azuma Y; Segawa K; Tohkin M; Omatsu H; Makimoto H; Hirai M; Saito Y
    J Clin Pharm Ther; 2013 Jun; 38(3):230-5. PubMed ID: 23530940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review and meta-analysis of risk factors for statin-induced myopathy.
    Nguyen KA; Li L; Lu D; Yazdanparast A; Wang L; Kreutz RP; Whipple EC; Schleyer TK
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1099-1109. PubMed ID: 29785580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of GATM polymorphism with statin-induced myopathy: a systematic review and meta-analysis.
    Liu M; Fan F; Zhang Y; Li J
    Eur J Clin Pharmacol; 2021 Mar; 77(3):349-357. PubMed ID: 33051696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin myopathy: a common dilemma not reflected in clinical trials.
    Fernandez G; Spatz ES; Jablecki C; Phillips PS
    Cleve Clin J Med; 2011 Jun; 78(6):393-403. PubMed ID: 21632911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of algorithms for the detection of statin myopathy signals from electronic medical records.
    Chan SL; Tham MY; Tan SH; Loke C; Foo B; Fan Y; Ang PS; Brunham LR; Sung C
    Clin Pharmacol Ther; 2017 May; 101(5):667-674. PubMed ID: 27706800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current overview of statin-induced myopathy.
    Rosenson RS
    Am J Med; 2004 Mar; 116(6):408-16. PubMed ID: 15006590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statin intolerance].
    Graversen CB; Larsen ML; Schmidt EB
    Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D.
    Riphagen IJ; van der Veer E; Muskiet FA; DeJongste MJ
    Curr Med Res Opin; 2012 Jul; 28(7):1247-52. PubMed ID: 22686958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin myotoxicity: a review of genetic susceptibility factors.
    Needham M; Mastaglia FL
    Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic predisposition to statin myopathy.
    Vladutiu GD
    Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis.
    Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM
    Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy.
    Stringer HA; Sohi GK; Maguire JA; Côté HC
    J Neurol Sci; 2013 Feb; 325(1-2):142-7. PubMed ID: 23312852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert opinion: the therapeutic challenges faced by statin intolerance.
    Patel J; Martin SS; Banach M
    Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in 45 patients with statin-associated myopathy.
    Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
    Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals.
    Luzum JA; Kitzmiller JP; Isackson PJ; Ma C; Medina MW; Dauki AM; Mikulik EB; Ochs-Balcom HM; Vladutiu GD
    Cell Metab; 2015 Apr; 21(4):622-7. PubMed ID: 25863251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.